Sage Therapeutics, Inc.

Sage Therapeutics, Inc.verified

SAGE

Price:

$8.68

Market Cap:

$544.94M

Sage Therapeutics, Inc. functions as a biopharmaceutical enterprise, dedicated to the discovery, development, and market introduction of therapeutic agents aimed at central nervous system (CNS) conditions. Its primary medication is ZULRESSO, an intravenous form of brexanolone, prescribed for the treatment of postpartum depression (PPD) in adult patients. The company's advanced pipeline includes zuranolone, a neuroactive steroid, which is presently undergoing Phase III clinical trials for several disorders, such as PPD, major depressive disorders, treatment-resistant depression, generalized anxiety disorders, and bipolar depression. Another investigational compound, SAGE-324, is in Phase II s...[Read more]

Industry

Biotechnology

IPO Date

2014-07-18

Stock Exchange

NASDAQ

Ticker

SAGE

The ROE as of June 2026 (TTM) for Sage Therapeutics, Inc. (SAGE) is -50.09%

According to Sage Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -50.09%. This represents a change of 202.69% compared to the average of -16.55% of the last 4 quarters.

Sage Therapeutics, Inc. (SAGE) Historical ROE (quarterly & annually)

How has SAGE ROE performed in the past?

The mean historical ROE of Sage Therapeutics, Inc. over the last ten years is -45.73%. The current -50.09% ROE has changed 9.54% with respect to the historical average. Over the past ten years (40 quarters), SAGE's ROE was at its highest in in the December 2020 quarter at 47.04%. The ROE was at its lowest in in the September 2017 quarter at -36.85%.

Quarterly (TTM)
Annual

Average

-45.73%

Median

-48.81%

Minimum

-86.15%

Maximum

29.25%

Sage Therapeutics, Inc. (SAGE) ROE by Quarter and Year

Discovering the peaks and valleys of Sage Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 96.12%

Maximum Annual ROE = 29.25%

Minimum Annual Increase = -189.15%

Minimum Annual ROE = -86.15%

Quarterly (TTM)
Annual
YearROEChange
2024-86.15%27.20%
2023-67.73%68.57%
2022-40.18%54.09%
2021-26.07%-189.15%
202029.25%-142.49%
2019-68.82%59.28%
2018-43.21%-23.94%
2017-56.81%31.68%
2016-43.14%-20.70%
2015-54.40%96.12%

Sage Therapeutics, Inc. (SAGE) Average ROE

How has SAGE ROE performed in the past?

The current ROE of Sage Therapeutics, Inc. (SAGE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-64.68%

5-year avg

-38.18%

10-year avg

-45.73%

Sage Therapeutics, Inc. (SAGE) ROE vs. Peers

How is SAGE’s ROE compared to its peers?

Sage Therapeutics, Inc.’s ROE is greater than Invivyd, Inc. (-53.48%), greater than Regulus Therapeutics Inc. (-30.84%), greater than iTeos Therapeutics, Inc. (-28.60%), greater than ARS Pharmaceuticals, Inc. (-153.61%), greater than Exscientia plc (-38.96%), greater than Climb Bio, Inc. (-31.46%), less than Revance Therapeutics, Inc. (466.15%), greater than Sinovac Biotech Ltd. (-1.13%), less than Niagen Bioscience Inc (25.38%), greater than Ikena Oncology, Inc. (-35.20%),

Build a custom stock screener for Sage Therapeutics, Inc. (SAGE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sage Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Sage Therapeutics, Inc. (SAGE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Sage Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Sage Therapeutics, Inc.'s ROE?

How is the ROE calculated for Sage Therapeutics, Inc. (SAGE)?

What is the highest ROE for Sage Therapeutics, Inc. (SAGE)?

What is the 3-year average ROE for Sage Therapeutics, Inc. (SAGE)?

What is the 5-year average ROE for Sage Therapeutics, Inc. (SAGE)?

How does the current ROE for Sage Therapeutics, Inc. (SAGE) compare to its historical average?